Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 16 shown

Commercialized according to BDPM

ROCLANDA 50 micrograms/ml + 200 micrograms/ml, eye drop solution

Active ingredients: Latanoprost, Netarsudil mesylate, Netarsudil

Original BDPM details in French

Official name: ROCLANDA 50 microgrammes/mL + 200 microgrammes/mL, collyre en solution
Active ingredients: LATANOPROST, MÉSYLATE DE NÉTARSUDIL, NÉTARSUDIL
Package description: 1 flacon polyéthylène basse densité (PEBD) de 2,5 mL avec embout avec fermeture à témoin d'effraction

CIS 64224662CIP7 3026392CIP13 3400930263921

View details

Estimated price€16.56No current ANSM shortage notice is included

Structural formula: Deferoxamine mesylate

Commercialized according to BDPM

DESFERAL 500 mg, powder and solvent for solution for injection

Active ingredients: Deferoxamine mesylate

Original BDPM details in French

Official name: DESFERAL 500 mg, poudre et solvant pour solution injectable
Active ingredients: MÉSILATE DE DÉFÉROXAMINE
Package description: 1 flacon(s) en verre de 500 mg - 1 ampoule(s) en verre de 5 ml

CIS 68537836CIP7 3029837CIP13 3400930298374

View details

Estimated price€12.60No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE ARROW LP 8 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE ARROW LP 8 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) PVC PVDC aluminium de 28 comprimé(s) en conditionnement calendaire

CIS 65525280CIP7 2165567CIP13 3400921655674

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE SUBSTIPHARM LP 4 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE SUBSTIPHARM LP 4 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) PVC PVDC aluminium de 28 comprimé(s)

CIS 61689364CIP7 2165366CIP13 3400921653663

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE SUBSTIPHARM LP 8 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE SUBSTIPHARM LP 8 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) PVC PVDC aluminium de 28 comprimé(s) en conditionnement calendaire

CIS 66978789CIP7 2165679CIP13 3400921656794

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE TEVA LP 4 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE TEVA LP 4 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) thermoformée(s) PVC PVDC aluminium de 28 comprimé(s)

CIS 67970560CIP7 3944641CIP13 3400939446417

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE VIATRIS L.P. 4 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE VIATRIS L.P. 4 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) aluminium de 28 comprimé(s)

CIS 60562606CIP7 3762561CIP13 3400937625616

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

DOXAZOSINE VIATRIS L.P. 8 mg, extended-release tablet

Active ingredients: Doxazosin, Doxazosin mesylate

Original BDPM details in French

Official name: DOXAZOSINE VIATRIS L.P. 8 mg, comprimé à libération prolongée
Active ingredients: DOXAZOSINE, MÉSILATE DE DOXAZOSINE
Package description: plaquette(s) aluminium de 28 comprimé(s)

CIS 67020316CIP7 3762578CIP13 3400937625784

View details

Estimated price€13.42No current ANSM shortage notice is included

Commercialized according to BDPM

FINLEE 10 mg, dispersible tablet

Active ingredients: DABRAFÉNIB, Dabrafenib mesylate

Original BDPM details in French

Official name: FINLEE 10 mg, comprimé dispersible
Active ingredients: DABRAFÉNIB, MÉSILATE DE DABRAFÉNIB
Package description: 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 210 comprimé(s) avec 2 gobelet(s) doseur(s)

CIS 61606482CIP7 3028119CIP13 3400930281192

View details

Estimated price€3,606.10No current ANSM shortage notice is included

Commercialized according to BDPM

LOJUXTA 10 mg, capsules

Active ingredients: Lomitapide, Lomitapide mesylate

Hard capsule

Original BDPM details in French

Official name: LOJUXTA 10 mg, gélules
Active ingredients: LOMITAPIDE, MÉSILATE DE LOMITAPIDE
Package description: flacon(s) polyéthylène haute densité (PEHD) de 28 gélule(s)

CIS 69243759CIP7 2762607CIP13 3400927626074

View details

Estimated price€41,222.16No current ANSM shortage notice is included

Commercialized according to BDPM

LOJUXTA 20 mg, capsules

Active ingredients: Lomitapide, Lomitapide mesylate

Hard capsule

Original BDPM details in French

Official name: LOJUXTA 20 mg, gélules
Active ingredients: LOMITAPIDE, MÉSILATE DE LOMITAPIDE
Package description: flacon(s) polyéthylène haute densité (PEHD) de 28 gélule(s)

CIS 69565055CIP7 2762613CIP13 3400927626135

View details

Estimated price€41,222.16No current ANSM shortage notice is included

Commercialized according to BDPM

LOJUXTA 5 mg, capsules

Active ingredients: Lomitapide, Lomitapide mesylate

Hard capsule

Original BDPM details in French

Official name: LOJUXTA 5 mg, gélules
Active ingredients: LOMITAPIDE, MÉSILATE DE LOMITAPIDE
Package description: flacon(s) polyéthylène haute densité (PEHD) de 28 gélule(s)

CIS 69851117CIP7 2762599CIP13 3400927625992

View details

Estimated price€41,222.16No current ANSM shortage notice is included

Commercialized according to BDPM

TAFINLAR 50 mg, hard capsule

Active ingredients: DABRAFÉNIB, Dabrafenib mesylate

Original BDPM details in French

Official name: TAFINLAR 50 mg, gélule
Active ingredients: DABRAFÉNIB, MÉSILATE DE DABRAFÉNIB
Package description: flacon(s) polyéthylène haute densité (PEHD) de 120 gélule(s)

CIS 61477322CIP7 2754967CIP13 3400927549670

View details

Estimated price€6,011.52No current ANSM shortage notice is included

Commercialized according to BDPM

TAFINLAR 75 mg, hard capsule

Active ingredients: DABRAFÉNIB, Dabrafenib mesylate

Original BDPM details in French

Official name: TAFINLAR 75 mg, gélule
Active ingredients: DABRAFÉNIB, MÉSILATE DE DABRAFÉNIB
Package description: flacon(s) polyéthylène haute densité (PEHD) de 120 gélule(s)

CIS 60248840CIP7 2754973CIP13 3400927549731

View details

Estimated price€8,883.40No current ANSM shortage notice is included

Commercialized according to BDPM

XADAGO 100 mg, film-coated tablet

Active ingredients: Safinamide mesylate, Safinamide

Original BDPM details in French

Official name: XADAGO 100 mg, comprimé pelliculé
Active ingredients: MÉTHANESULFONATE DE SAFINAMIDE, SAFINAMIDE
Package description: plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)

CIS 66932795CIP7 3001340CIP13 3400930013403

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

XADAGO 50 mg, film-coated tablet

Active ingredients: Safinamide mesylate, Safinamide

Original BDPM details in French

Official name: XADAGO 50 mg, comprimé pelliculé
Active ingredients: MÉTHANESULFONATE DE SAFINAMIDE, SAFINAMIDE
Package description: plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)

CIS 61882445CIP7 3001337CIP13 3400930013373

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.